Unknown

Dataset Information

0

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.


ABSTRACT: Virion glycoproteins such as glycoprotein D (gD) are believed to be the dominant antigens of herpes simplex virus 2 (HSV-2). We have observed that mice immunized with a live HSV-2 ICP0- mutant virus, HSV-2 0?NLS, are 10 to 100 times better protected against genital herpes than mice immunized with a HSV-2 gD subunit vaccine (PLoS ONE 6:e17748). In light of these results, we sought to determine which viral proteins were the dominant antibody-generators (antigens) of the live HSV-2 0?NLS vaccine. Western blot analyses indicated the live HSV-2 0?NLS vaccine elicited an IgG antibody response against 9 or more viral proteins. Many antibodies were directed against infected-cell proteins of >100 kDa in size, and only 10 ± 5% of antibodies were directed against gD. Immunoprecipitation (IP) of total HSV-2 antigen with 0?NLS antiserum pulled down 19 viral proteins. Mass spectrometry suggested 44% of immunoprecipitated viral peptides were derived from two HSV-2 infected cells proteins, RR-1 and ICP8, whereas only 14% of immunoprecipitated peptides were derived from HSV-2's thirteen glycoproteins. Collectively, the results suggest the immune response to the live HSV-2 0?NLS vaccine includes antibodies specific for infected cell proteins, capsid proteins, tegument proteins, and glycoproteins. This increased breadth of antibody-generating proteins may contribute to the live HSV-2 vaccine's capacity to elicit superior protection against genital herpes relative to a gD subunit vaccine.

SUBMITTER: Geltz JJ 

PROVIDER: S-EPMC4319894 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.

Geltz Joshua J JJ   Gershburg Edward E   Halford William P WP  

PloS one 20150206 2


Virion glycoproteins such as glycoprotein D (gD) are believed to be the dominant antigens of herpes simplex virus 2 (HSV-2). We have observed that mice immunized with a live HSV-2 ICP0- mutant virus, HSV-2 0ΔNLS, are 10 to 100 times better protected against genital herpes than mice immunized with a HSV-2 gD subunit vaccine (PLoS ONE 6:e17748). In light of these results, we sought to determine which viral proteins were the dominant antibody-generators (antigens) of the live HSV-2 0ΔNLS vaccine. W  ...[more]

Similar Datasets

| S-EPMC4840408 | biostudies-literature
| S-EPMC8402837 | biostudies-literature
2017-09-13 | GSE103763 | GEO
| S-EPMC3055896 | biostudies-literature
2017-08-10 | GSE102470 | GEO
| S-EPMC5723348 | biostudies-literature
| S-EPMC4136817 | biostudies-literature
| S-EPMC5853346 | biostudies-literature
| S-EPMC4939147 | biostudies-literature
| S-EPMC2394846 | biostudies-literature